Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Risk stratification biomarkers for Staphylococcus aureus bacteraemia.

Cao Y, Guimaraes AO, Peck MC, Mayba O, Ruffin F, Hong K, Carrasco-Triguero M, Fowler VG Jr, Maskarinec SA, Rosenberger CM.

Clin Transl Immunology. 2020 Feb 13;9(2):e1110. doi: 10.1002/cti2.1110. eCollection 2020.

2.

Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia.

Guimaraes AO, Gutierrez J, Maskarinec SA, Cao Y, Hong K, Ruffin F, Carrasco-Triguero M, Peck MC, Fowler VG, Baruch A, Rosenberger CM.

Open Forum Infect Dis. 2019 Mar 15;6(4):ofz126. doi: 10.1093/ofid/ofz126. eCollection 2019 Apr.

3.

Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia.

Gutierrez J, Guimaraes AO, Lewin-Koh N, Berhanu A, Xu M, Cao Y, Kim J, Yan D, Chang JK, Dinoso JB, Koss CA, Clemenzi-Allen A, Chambers HF, Peck MC, Baruch A, Rosenberger CM.

Open Forum Infect Dis. 2019 Feb 26;6(4):ofz090. doi: 10.1093/ofid/ofz090. eCollection 2019 Apr.

4.

A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection.

Guimaraes AO, Cao Y, Hong K, Mayba O, Peck MC, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso JB, Clemenzi-Allen A, Koss CA, Maskarinec SA, Chambers HF, Fowler VG, Baruch A, Rosenberger CM.

Clin Infect Dis. 2019 Apr 24;68(9):1502-1511. doi: 10.1093/cid/ciy739.

5.

Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".

McBride JM, Lim JJ, Burgess T, Deng R, Derby MA, Maia M, Horn P, Siddiqui O, Sheinson D, Chen-Harris H, Newton EM, Fillos D, Nazzal D, Rosenberger CM, Ohlson MB, Lambkin-Williams R, Fathi H, Harris JM, Tavel JA.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02034-17. doi: 10.1128/AAC.02034-17. Print 2018 Jan. No abstract available.

6.

Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.

McBride JM, Lim JJ, Burgess T, Deng R, Derby MA, Maia M, Horn P, Siddiqui O, Sheinson D, Chen-Harris H, Newton EM, Fillos D, Nazzal D, Rosenberger CM, Ohlson MB, Lambkin-Williams R, Fathi H, Harris JM, Tavel JA.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01154-17. doi: 10.1128/AAC.01154-17. Print 2017 Nov.

7.

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.

Allen EK, Randolph AG, Bhangale T, Dogra P, Ohlson M, Oshansky CM, Zamora AE, Shannon JP, Finkelstein D, Dressen A, DeVincenzo J, Caniza M, Youngblood B, Rosenberger CM, Thomas PG.

Nat Med. 2017 Aug;23(8):975-983. doi: 10.1038/nm.4370. Epub 2017 Jul 17.

8.

Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.

Randolph AG, Yip WK, Allen EK, Rosenberger CM, Agan AA, Ash SA, Zhang Y, Bhangale TR, Finkelstein D, Cvijanovich NZ, Mourani PM, Hall MW, Su HC, Thomas PG; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Pediatric Influenza (PICFLU) Investigators; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Pediatric Influenza (PICFLU) Investigators.

J Infect Dis. 2017 Jul 1;216(1):14-21. doi: 10.1093/infdis/jix242.

9.

miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis.

Rosenberger CM, Podyminogin RL, Diercks AH, Treuting PM, Peschon JJ, Rodriguez D, Gundapuneni M, Weiss MJ, Aderem A.

PLoS Pathog. 2017 Apr 5;13(4):e1006305. doi: 10.1371/journal.ppat.1006305. eCollection 2017 Apr.

10.

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01794-16. doi: 10.1128/AAC.01794-16. Print 2017 Feb.

11.

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMABâ„¢ antibody antibiotic conjugate against Staphylococcus aureus in mice.

Zhou C, Lehar S, Gutierrez J, Rosenberger CM, Ljumanovic N, Dinoso J, Koppada N, Hong K, Baruch A, Carrasco-Triguero M, Saad O, Mariathasan S, Kamath AV.

MAbs. 2016 Nov/Dec;8(8):1612-1619. Epub 2016 Sep 21.

12.

Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.

Jegaskanda S, Luke C, Hickman HD, Sangster MY, Wieland-Alter WF, McBride JM, Yewdell JW, Wright PF, Treanor J, Rosenberger CM, Subbarao K.

J Infect Dis. 2016 Sep 15;214(6):945-52. doi: 10.1093/infdis/jiw262. Epub 2016 Jun 28.

13.

A comprehensive collection of systems biology data characterizing the host response to viral infection.

Aevermann BD, Pickett BE, Kumar S, Klem EB, Agnihothram S, Askovich PS, Bankhead A 3rd, Bolles M, Carter V, Chang J, Clauss TR, Dash P, Diercks AH, Eisfeld AJ, Ellis A, Fan S, Ferris MT, Gralinski LE, Green RR, Gritsenko MA, Hatta M, Heegel RA, Jacobs JM, Jeng S, Josset L, Kaiser SM, Kelly S, Law GL, Li C, Li J, Long C, Luna ML, Matzke M, McDermott J, Menachery V, Metz TO, Mitchell H, Monroe ME, Navarro G, Neumann G, Podyminogin RL, Purvine SO, Rosenberger CM, Sanders CJ, Schepmoes AA, Shukla AK, Sims A, Sova P, Tam VC, Tchitchek N, Thomas PG, Tilton SC, Totura A, Wang J, Webb-Robertson BJ, Wen J, Weiss JM, Yang F, Yount B, Zhang Q, McWeeney S, Smith RD, Waters KM, Kawaoka Y, Baric R, Aderem A, Katze MG, Scheuermann RH.

Sci Data. 2014 Oct 14;1:140033. doi: 10.1038/sdata.2014.33. eCollection 2014.

14.

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model.

Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, McClaren JL, Tam VC, Dash P, Noonan JG, Jones BG, Surman SL, Peschon JJ, Diercks AH, Hurwitz JL, Doherty PC, Thomas PG, Aderem A.

J Gen Virol. 2014 Feb;95(Pt 2):350-62. doi: 10.1099/vir.0.058438-0. Epub 2013 Nov 16.

15.

Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.

Askovich PS, Sanders CJ, Rosenberger CM, Diercks AH, Dash P, Navarro G, Vogel P, Doherty PC, Thomas PG, Aderem A.

PLoS One. 2013 Sep 20;8(9):e74863. doi: 10.1371/journal.pone.0074863. eCollection 2013.

16.

miR-451 regulates dendritic cell cytokine responses to influenza infection.

Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A.

J Immunol. 2012 Dec 15;189(12):5965-75. doi: 10.4049/jimmunol.1201437. Epub 2012 Nov 19.

17.

Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection.

Valdez Y, Diehl GE, Vallance BA, Grassl GA, Guttman JA, Brown NF, Rosenberger CM, Littman DR, Gros P, Finlay BB.

Cell Microbiol. 2008 Aug;10(8):1646-61. doi: 10.1111/j.1462-5822.2008.01155.x. Epub 2008 Apr 7.

18.

Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics.

Ramsey SA, Klemm SL, Zak DE, Kennedy KA, Thorsson V, Li B, Gilchrist M, Gold ES, Johnson CD, Litvak V, Navarro G, Roach JC, Rosenberger CM, Rust AG, Yudkovsky N, Aderem A, Shmulevich I.

PLoS Comput Biol. 2008 Mar 21;4(3):e1000021. doi: 10.1371/journal.pcbi.1000021. Erratum in: PLoS Comput Biol. 2008 Mar;4(3). doi: 10.1371/annotation/1c55be5f-ecd7-49be-91c1-91881be60297. PLoS Comput Biol. 2008 Mar;4(3). doi: 10.1371/annotation/e14ad837-e5ff-4bd5-a5f2-f32e784d75a2.

19.

The Innate Immune Database (IIDB).

Korb M, Rust AG, Thorsson V, Battail C, Li B, Hwang D, Kennedy KA, Roach JC, Rosenberger CM, Gilchrist M, Zak D, Johnson C, Marzolf B, Aderem A, Shmulevich I, Bolouri H.

BMC Immunol. 2008 Mar 5;9:7. doi: 10.1186/1471-2172-9-7.

20.

ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells.

Rosenberger CM, Clark AE, Treuting PM, Johnson CD, Aderem A.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2544-9. doi: 10.1073/pnas.0712182105. Epub 2008 Feb 11.

21.

Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.

Khan MA, Bouzari S, Ma C, Rosenberger CM, Bergstrom KS, Gibson DL, Steiner TS, Vallance BA.

Infect Immun. 2008 Apr;76(4):1410-22. doi: 10.1128/IAI.01141-07. Epub 2008 Jan 28.

22.

Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis.

Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, Huang JT, Khan MA, Vallance BA.

Cell Microbiol. 2008 Feb;10(2):388-403. Epub 2007 Oct 2.

PMID:
17910742
23.

IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.

Davidson DJ, Currie AJ, Bowdish DM, Brown KL, Rosenberger CM, Ma RC, Bylund J, Campsall PA, Puel A, Picard C, Casanova JL, Turvey SE, Hancock RE, Devon RS, Speert DP.

J Immunol. 2006 Dec 1;177(11):8202-11.

24.

Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, Deng W, Finlay BB, Vallance BA.

Infect Immun. 2006 May;74(5):2522-36.

25.

Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates.

Pollard AJ, Currie A, Rosenberger CM, Heale JP, Finlay BB, Speert DP.

Cell Microbiol. 2004 Jul;6(7):639-50.

PMID:
15186400
26.

Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication.

Rosenberger CM, Gallo RL, Finlay BB.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2422-7.

27.

Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens.

Rosenberger CM, Finlay BB.

Nat Rev Mol Cell Biol. 2003 May;4(5):385-96. Review.

PMID:
12728272
28.

Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities.

Rosenberger CM, Finlay BB.

J Biol Chem. 2002 May 24;277(21):18753-62. Epub 2002 Jan 30.

29.

Gene array technology to determine host responses to Salmonella.

Rosenberger CM, Pollard AJ, Finlay BB.

Microbes Infect. 2001 Nov-Dec;3(14-15):1353-60. Review.

PMID:
11755425
30.
31.

SifA permits survival and replication of Salmonella typhimurium in murine macrophages.

Brumell JH, Rosenberger CM, Gotto GT, Marcus SL, Finlay BB.

Cell Microbiol. 2001 Feb;3(2):75-84.

PMID:
11207622
32.

Microbial pathogenesis: lipid rafts as pathogen portals.

Rosenberger CM, Brumell JH, Finlay BB.

Curr Biol. 2000 Nov 16;10(22):R823-5. Review.

33.
34.

Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression.

Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB.

J Immunol. 2000 Jun 1;164(11):5894-904.

Supplemental Content

Loading ...
Support Center